Related Experiment Video
Updated: Apr 19, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
21.2K
[Interstitial lung diseases in rheumatological diseases]
Pneumologie (Stuttgart, Germany)
|April 17, 2026
Summary
Interstitial lung disease (ILD) risk is low but significantly higher with rheumatic disorders, causing severe illness and death. Early diagnosis and treatment are vital for better patient outcomes.
Area of Science:
- Rheumatology
- Pulmonology
- Radiology
Background:
- Interstitial lung disease (ILD) affects approximately 0.07% of the general population.
- Rheumatic diseases substantially elevate the risk of developing ILD, leading to significant morbidity and mortality.
- Clinical presentations of ILD are diverse, ranging from asymptomatic cases to acute respiratory failure, often delaying diagnosis.
Purpose of the Study:
- To highlight the importance of early recognition and prompt intervention for ILD associated with rheumatic disorders.
- To outline current diagnostic and management strategies for rheumatic ILD.
- To emphasize the need for interdisciplinary collaboration in managing these complex cases.
Main Methods:
- Pulmonary function testing, including body plethysmography and diffusing capacity for carbon monoxide (DLCO).
- High-resolution computed tomography (HRCT) for characteristic radiologic patterns (UIP, NSIP).
- Multidisciplinary ILD board discussions involving rheumatologists, pulmonologists, and radiologists.
Main Results:
- Characteristic radiologic patterns on HRCT aid in disease stratification and prognosis.
- High-dose glucocorticoids are used for acute/subacute inflammation, with minimized long-term steroid use.
- Management combines immunomodulatory agents (DMARDs) and antifibrotic therapies for progressive disease.
Conclusions:
- Accurate classification and individualized treatment planning require multidisciplinary input.
- Interdisciplinary follow-up is crucial for early detection of progression and optimizing patient outcomes.
- Current strategies focus on a combination of immunomodulation and antifibrotic therapies.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
991
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
991
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
1.2K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K
01:17Other Pulmonary Disorders
2.0K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.7K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.7K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.3K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.2K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.2K